Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in STN DBS surgery
NCT01721460Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in Parkinson's disease (PD), sponsored by University of Wisconsin–Madison. Primary endpoint: Change in Average Population Spiking Activity. Started Nov 2012; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01721460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01721460.